| COVID-19 |
1 |
1 |
| Biliary Disease |
0 |
0.9 |
| Metabolic Syndrome |
0 |
0.98 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.95 |
| Fatty Liver |
0 |
0.84 |
| Metabolic Liver Disease |
0 |
0.99 |
| Liver |
0 |
0.74 |
| Liver Disease |
0 |
0.73 |
| Metabolism |
0 |
0.44 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.25 |
| Steatosis |
0 |
0.2 |
| HIV Infection |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Acute Respiratory Distress Syndrome |
0 |
0.08 |
| Hepatitis |
0 |
0.08 |
| Biliary Tract |
0 |
0.07 |
| Hepatitis B Virus |
0 |
0.07 |
| Mechanical Ventilation |
0 |
0.07 |
| Bile |
0 |
0.05 |
| Canada |
0 |
0.05 |
| Glucocorticoid |
0 |
0.05 |
| Injury |
0 |
0.05 |
| Severe Acute Respiratory Syndrome |
0 |
0.05 |
| Type 2 Diabetes Mellitus |
0 |
0.05 |
| Wound Management |
0 |
0.05 |